![Structural Evolution and Translational Potential for Agonists and Antagonists of Endosomal Toll-like Receptors | Journal of Medicinal Chemistry Structural Evolution and Translational Potential for Agonists and Antagonists of Endosomal Toll-like Receptors | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c00300/asset/images/large/jm1c00300_0046.jpeg)
Structural Evolution and Translational Potential for Agonists and Antagonists of Endosomal Toll-like Receptors | Journal of Medicinal Chemistry
![Antibodies | Free Full-Text | Combined Anti-Cancer Strategies Based on Anti-Checkpoint Inhibitor Antibodies Antibodies | Free Full-Text | Combined Anti-Cancer Strategies Based on Anti-Checkpoint Inhibitor Antibodies](https://www.mdpi.com/antibodies/antibodies-09-00017/article_deploy/html/images/antibodies-09-00017-g001.png)
Antibodies | Free Full-Text | Combined Anti-Cancer Strategies Based on Anti-Checkpoint Inhibitor Antibodies
Proteolytic Cleavage—Mechanisms, Function, and “Omic” Approaches for a Near-Ubiquitous Posttranslational Modification | Chemical Reviews
![Current Oncology | Free Full-Text | Impact of Value Frameworks on the Magnitude of Clinical Benefit: Evaluating a Decade of Randomized Trials for Systemic Therapy in Solid Malignancies Current Oncology | Free Full-Text | Impact of Value Frameworks on the Magnitude of Clinical Benefit: Evaluating a Decade of Randomized Trials for Systemic Therapy in Solid Malignancies](https://www.mdpi.com/curroncol/curroncol-28-00412/article_deploy/html/images/curroncol-28-00412-g001.png)